Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Oct 8;7(10):e018015.
doi: 10.1136/bmjopen-2017-018015.

Recruitment, adherence, and retention of endometrial cancer survivors in a behavioural lifestyle programme: the Diet and Exercise in Uterine Cancer Survivors (DEUS) parallel randomised pilot trial

Dimitrios A Koutoukidis  1   2 , Rebecca J Beeken  2   3 , Ranjit Manchanda  1   4   5 , Moscho Michalopoulou  1 , Matthew Burnell  1 , M Tish Knobf  1   6 , Anne Lanceley  1
Affiliations
Randomized Controlled Trial

Recruitment, adherence, and retention of endometrial cancer survivors in a behavioural lifestyle programme: the Diet and Exercise in Uterine Cancer Survivors (DEUS) parallel randomised pilot trial

Dimitrios A Koutoukidis et al. BMJ Open. .

Abstract

Objective: Healthy eating and physical activity may help endometrial cancer survivors (ECS) improve their quality of life. However, most ECS do not meet the relevant guidelines. This pilot trial aimed to test the study feasibility procedures for a definitive trial of a behavioural lifestyle programme.

Design and setting: This 24-week parallel two-arm randomised pilot trial took place in two hospitals in London, UK (April 2015-June 2016).

Participants: Sixty disease-free ECS within 3 years of diagnosis.

Interventions: Participants were randomised using minimisation to receive the intervention or care as usual. The 'Shape-Up following cancer treatment' programme used self-monitoring, goal-setting, self-incentives, problem-solving and group social support for 12 hours over 8 weeks to help survivors improve their eating and physical activity.

Outcome measures: The main outcome measures were recruitment, adherence, and retention rates. Further outcomes included barriers to participation and feedback on programme satisfaction.

Results: Of the 296 potentially eligible ECS, 20% (n=60) were randomly allocated to the active intervention (n=29) or control group (n=31). Three participants in each arm were deemed ineligible after randomisation and excluded from analysis. Twenty participants (77%; 95% CI 61% to 93%) adhered to the intervention and provided generally favourable feedback. At 24 weeks, 25/26 (96%; 95% CI 89% to 100%) intervention and 24/28 (86%; 95% CI 73% to 99%) control participants completed their assessment. No intervention-related adverse events were reported. Among eligible survivors who declined study participation (n=83), inconvenience (78%; 95% CI 69% to 87%) was the most common barrier.

Conclusions: The trial was feasible to deliver based on the a priori feasibility criteria. Enhancing recruitment and adherence in a definitive trial will require designs that promote convenience and consider ECS-reported barriers.

Trial registration number: NCT02433080; Pre-results.

Trial funding: University College London, St. Bartholomew's Hospital Nurses League, and NIHR University College London Hospitals Biomedical Research Centre.

Keywords: Endometrial cancer; behaviour change; healthy eating; intervention; physical activity; survivorship.

PubMed Disclaimer

Conflict of interest statement

Competing interests: DAK and RJB are volunteers for the charity Weight Concern, which developed the original Shape-Up programme for the general population. All other authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Consolidated Standards of Reporting Trials diagram of the trial with framework on barriers to participation in the exclusion box. wk, week.
See this image and copyright information in PMC

References

    1. Fitzmaurice C, Allen C, Barber RM, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol 2017;3:524–48. 10.1001/jamaoncol.2016.5688 - DOI - PMC - PubMed
    1. Quaresma M, Coleman MP, Rachet B. 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971-2011: a population-based study. Lancet 2015;385:1206–18. 10.1016/S0140-6736(14)61396-9 - DOI - PubMed
    1. Leach CR, Weaver KE, Aziz NM, et al. The complex health profile of long-term cancer survivors: prevalence and predictors of comorbid conditions. J Cancer Surviv 2015;9:239–51. 10.1007/s11764-014-0403-1 - DOI - PubMed
    1. Ward KK, Shah NR, Saenz CC, et al. Cardiovascular disease is the leading cause of death among endometrial cancer patients. Gynecol Oncol 2012;126:176–9. 10.1016/j.ygyno.2012.04.013 - DOI - PubMed
    1. Koutoukidis DA, Knobf MT, Lanceley A. Obesity, diet, physical activity, and health-related quality of life in endometrial cancer survivors. Nutr Rev 2015;73:399–408. 10.1093/nutrit/nuu063 - DOI - PMC - PubMed

Publication types

Associated data